MA21902A1 - PROCESS FOR THE PREPARATION OF HEMOREGULATING PEPTITIDES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME. - Google Patents

PROCESS FOR THE PREPARATION OF HEMOREGULATING PEPTITIDES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME.

Info

Publication number
MA21902A1
MA21902A1 MA22171A MA22171A MA21902A1 MA 21902 A1 MA21902 A1 MA 21902A1 MA 22171 A MA22171 A MA 22171A MA 22171 A MA22171 A MA 22171A MA 21902 A1 MA21902 A1 MA 21902A1
Authority
MA
Morocco
Prior art keywords
peptitides
hemoregulating
preparation
same
pharmaceutical compositions
Prior art date
Application number
MA22171A
Other languages
French (fr)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA21902A1 publication Critical patent/MA21902A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides compounds of the general formula: <CHEM> The compounds have hemoregulatory activities and can be used to stimulate haematopoiesis.
MA22171A 1989-07-14 1990-07-13 PROCESS FOR THE PREPARATION OF HEMOREGULATING PEPTITIDES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME. MA21902A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38057889A 1989-07-14 1989-07-14

Publications (1)

Publication Number Publication Date
MA21902A1 true MA21902A1 (en) 1991-04-01

Family

ID=23501712

Family Applications (1)

Application Number Title Priority Date Filing Date
MA22171A MA21902A1 (en) 1989-07-14 1990-07-13 PROCESS FOR THE PREPARATION OF HEMOREGULATING PEPTITIDES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME.

Country Status (24)

Country Link
EP (1) EP0408371B1 (en)
JP (1) JP2638666B2 (en)
KR (1) KR910002899A (en)
CN (1) CN1034663C (en)
AT (1) ATE112289T1 (en)
AU (1) AU638468B2 (en)
CA (1) CA2020838C (en)
DE (1) DE69012901T2 (en)
DK (1) DK0408371T3 (en)
ES (1) ES2064642T3 (en)
FI (1) FI94354C (en)
HU (1) HU206889B (en)
IE (1) IE65533B1 (en)
IL (1) IL95012A (en)
MA (1) MA21902A1 (en)
MX (1) MX21581A (en)
MY (1) MY106352A (en)
NO (1) NO177713C (en)
NZ (1) NZ234501A (en)
PH (1) PH30055A (en)
PL (2) PL165133B1 (en)
PT (1) PT94702B (en)
ZA (1) ZA905505B (en)
ZW (1) ZW11290A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW222280B (en) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211677D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
US5610141A (en) * 1992-06-02 1997-03-11 Nycomed Imaging As Double chain peptide compounds having hemoregulatory activity
GB9211668D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
ES2052447B1 (en) * 1992-12-14 1995-01-16 Smithkline Beecham Corp HEMOREGULATORY PEPTIDES.
JPH08510258A (en) * 1993-05-14 1996-10-29 マリンクロット・メディカル・インコーポレイテッド Ligand precursor for incorporation into peptides
ES2210255T3 (en) * 1993-06-08 2004-07-01 Smithkline Beecham Corporation METHODS TO IMPROVE THE BIOLOGICAL ACTIVITY OF CHEMIOCINES.
GB9314200D0 (en) * 1993-07-09 1993-08-18 Hafslund Nycomed As Peptide compounds
DE69420044T2 (en) * 1993-10-29 2000-03-23 Smithkline Beecham Corp., King Of Prussia BLOOD REGULATING PEPTIDES
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
AU719216B2 (en) * 1996-02-13 2000-05-04 Akzo Nobel N.V. Serine protease inhibitors
IL120310A (en) 1996-03-01 2002-02-10 Akzo Nobel Nv Serine protease inhibitors and pharmaceutical compositions containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47421B1 (en) * 1977-06-08 1984-03-07 Merck & Co Inc Somatostatin analogs,process for their preparation and pharmaceutical compositions containing them
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
NZ234501A (en) 1991-08-27
NO177713C (en) 1995-11-08
PL286043A1 (en) 1991-03-25
PT94702A (en) 1991-03-20
HUT55034A (en) 1991-04-29
JP2638666B2 (en) 1997-08-06
CA2020838A1 (en) 1991-01-15
DE69012901D1 (en) 1994-11-03
ZA905505B (en) 1991-04-24
ZW11290A1 (en) 1990-10-31
KR910002899A (en) 1991-02-26
MX21581A (en) 1994-01-31
EP0408371A1 (en) 1991-01-16
NO903148D0 (en) 1990-07-13
ES2064642T3 (en) 1995-02-01
JPH0356498A (en) 1991-03-12
HU904201D0 (en) 1990-12-28
IE902547A1 (en) 1991-02-27
NO177713B (en) 1995-07-31
PT94702B (en) 1997-04-30
CN1034663C (en) 1997-04-23
PH30055A (en) 1996-11-08
DE69012901T2 (en) 1995-02-16
FI903571A0 (en) 1990-07-13
PL166004B1 (en) 1995-03-31
IL95012A (en) 1995-03-15
NO903148L (en) 1991-01-15
HK1004554A1 (en) 1998-11-27
IE65533B1 (en) 1995-11-01
AU638468B2 (en) 1993-07-01
FI94354C (en) 1995-08-25
EP0408371B1 (en) 1994-09-28
CN1054773A (en) 1991-09-25
FI94354B (en) 1995-05-15
IL95012A0 (en) 1991-06-10
AU5901490A (en) 1991-01-17
CA2020838C (en) 2000-05-02
ATE112289T1 (en) 1994-10-15
HU206889B (en) 1993-01-28
MY106352A (en) 1995-05-30
PL165133B1 (en) 1994-11-30
DK0408371T3 (en) 1996-12-16

Similar Documents

Publication Publication Date Title
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
NZ236589A (en) A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions
PT87820A (en) PROCESS FOR THE PREPARATION OF 1,2,3,5,6-TETRAHYDRO-PYRIDILE ANOF PYPERIDILE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREWI
FR2435248A1 (en) 4-ANILINOQUINAZOLINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FI944823A0 (en) Galantamine derivatives, method of their preparation and their use in drugs
ES8606282A1 (en) A PROCEDURE FOR PREPARING QUINOLIN-YNAFTIRIDIN-CARBOXYL ACID DERIVATIVES
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
PT82512A (en) PROCESS FOR THE PREPARATION OF QUINOLYLGLYCINAMIDE DERIVATIVES HAVING PSYCHOTROPIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2392959A1 (en) AMINO ACIDS AND PROCESS FOR OBTAINING
FR2446829A1 (en) POLYMETHYLENE DERIVATIVES DISUBSTITUTED IN ALPHA, OMEGA, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RO79385A (en) PROCESS FOR THE PREPARATION OF 1,2,3-THIADIAZOLE-5-CARBOXYLIC ACID DERIVATIVE DERIVATIVES
PT87301A (en) PROCESS FOR THE PREPARATION OF 1,3-DIOXANES BY PRODUCTS AND OF PHARMACEUTICAL COMPOUNDS CONTAINING THEM
PT77429A (en) PROCESS FOR THE PREPARATION OF NOVEL N- (AMINO-METHYL-5-OXAZOLIN-2-YL) -N-PHENYLUREES AND COMPOSITIONS CONTAINING SAME
FR2585020B1 (en) NOVEL BIOLOGICALLY ACTIVE SUBSTANCE, CALLED GIROLLIN, EXTRACTED FROM THE SPONGE PSEUDAXINYSSA CANTHARELLA, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
DE59008844D1 (en) Benzylselenobenzamides of aminopyridines and picolylamines.
FR2593812B1 (en) NA-SUBSTITUTED DERIVATIVES OF NA-ARYLSULFONYLAMINOACYL P-AMIDINOPHENYLALANINAMIDES, PROCESS FOR THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
ES2052133T3 (en) PICOLILSELENIO-BENZAMIDES OF AMINOPYRIDINES, ANILINS AND PICOLYLAMINES.
DE3576687D1 (en) CHINATE SALT OF THE ANTIMALARIAN COMPOUND MEFLOQUIN.
PT80082A (en) PROCESS FOR THE PREPARATION OF OMEGA - &lt;(2-HYDROXY-PHENYL) -METHYLENE-AMINO&gt; -PHENYL-ALKANECARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
PT77752B (en) PROCESS FOR THE PREPARATION OF ALKYL BENZYLIDENIC DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
MA22731A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS